Program at a Glance

Click on the links below to be directed to specific days. Please note that the time zone in the table below is in Eastern Standard Time (EST).

The program is subject to change. Session topics, descriptions and presenters will be added as information is confirmed.  

Friday, March 4

**Time is in Eastern Standard Time (EST). Click here to find your local time.
 All Day
  •  ISOPP Initiatives and Sponsor and Exhibitors Gallery 
  •  Meeting Hub: Connect with colleagues from around the world!
 08:00-08:15   

 Welcome Remarks

 08:15-08:45

 Networking

 08:45-10:15

 Opening Plenary - The Patient Experience During COVID-19
 
Heidi Finnes, USA and Evalyn Allela, Cipla Kenya, Kenya 

 10:15-10:45

 Visit:

  • ISOPP Initiatives and Sponsor and Exhibitors Gallery
  • Meeting Hub to connect with colleagues from around the world!
 10:45-11:45

 Sponsored Symposium: BD - Introducing a novel CSTD to protect healthcare workers and a reduce contamination across preparation and administration areas in multisite health system

 11:45-12:15

 Networking 

 12:15-13:00  Concurrent Sessions

  Extravasation Management: Specific Pharmacological and Non-Pharmacological Measures And Antineoplastic Tissue Risk Classification
 María Asunción Albert-Marí, Hospital Universitario y Politecnico La Fe, Spain

 Immunotherapy Updates in Solid Tumor Malignancies
 Jared Borlagdan, Oregon Health and Science University (OHSU), USA

Saturday, March 5
**Time is in Eastern Standard Time (EST). Click here to find your local time.
 All Day
 
  •  ISOPP Initiatives and Sponsor and Exhibitors Gallery 
  •  Meeting Hub: Connect with colleagues from around the world!
 08:00-09:00  Plenary - Can immunotherapy contribute to a vision of precision cancer medicine?
 Elaine Vickers, Science Communicated Ltd, UK 
 09:00-10:00

 ISOPP Annual General Meeting (AGM)
 Strategic Plan and Standards Update

 10:00-10:30

Visit:

  • ISOPP Initiatives and Sponsor and Exhibitors Gallery
  • Meeting Hub to connect with colleagues from around the world!
 10:30-11:30  Plenary - EviQ Renal Dysfunction Dosing Guideline Update
 Jolanta Małyszko, Poczta Onet, Poland 
 Michael Michael, Peter MacCallum Cancer Centre, Australia 
 Geeta Sandhu, Cancer Institute NSW, Australia
 Carla Scuderi, Queensland Health, Australia 
 Ben Sprangers, University Hospitals Leuven, Belgium
 11:30-12:30

 Hot Topic Discussions led by facilitators

 12:30-13:15  Plenary- Immunotherapy Dosing
 Alison Palumbo, Oregon Health and Science University (OHSU), USA 
 13:15-13:45  Highlights of the Symposium and Closing Remarks

 
Sign up for ISOPP’s Community Newsletter to receive updates on the program. If you are an ISOPP member, you are already signed up.